13m
SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback